FDA Orange Book · active-ingredient family
Desmopressin acetate
Desmopressin acetate is approved as 10 brand and 28 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DESMODA · NDA 219873
10
Brand (NDA)
28
Generics (ANDA)
9
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, solution, spray, metered, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DESMODARLD | ETON | NDA 219873 | — | Feb 25, 2026 | |
| NOCDURNARLD×2 | FERRING PHARMS INC | NDA 022517 | — | Jun 21, 2018 | |
| NOCTIVARLD×2 | ACERUS PHARMS | NDA 201656 | — | Mar 03, 2017 | |
| STIMATE (NEEDS NO REFRIGERATION)RLD×2 | FERRING PHARMS INC | NDA 020355 | — | Oct 24, 2007 | |
| MINIRINRLD | FERRING | NDA 021333 | — | Sep 16, 2002 | |
| DDAVPRLD×2 | FERRING PHARMS INC | NDA 019955 | AB | Sep 06, 1995 | |
| DDAVPRLD×2 | NORDIC PHARMA | NDA 018938 | AP | Mar 30, 1984 | |
| DDAVPRLD×3 | FERRING PHARMS INC | NDA 017922 | — | Approved Prior to Jan 1, 1982 | |
| DESMOPRESSIN ACETATE×2 | FERRING | NDA 021795 | — | May 08, 2008 | |
| CONCENTRAID | FERRING | NDA 019776 | — | Dec 26, 1990 |
Generic (ANDA) products (28)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DESMOPRESSIN ACETATE | CAPLIN | ANDA 219981 | AP | Feb 27, 2026 | |
| DESMOPRESSIN ACETATE×2 | AUROBINDO PHARMA | ANDA 213095 | AB | Mar 21, 2024 | |
| DESMOPRESSIN ACETATE | GLAND | ANDA 216904 | AP | Mar 20, 2023 | |
| DESMOPRESSIN ACETATE | GLAND | ANDA 216922 | AP | Nov 16, 2022 | |
| DESMOPRESSIN ACETATE | DR REDDYS | ANDA 215961 | AP | Aug 19, 2022 | |
| DESMOPRESSIN ACETATE | UBI | ANDA 210223 | AP | Sep 17, 2020 | |
| DESMOPRESSIN ACETATE | UBI | ANDA 210218 | AP | Feb 14, 2020 | |
| DESMOPRESSIN ACETATE×2 | NOVAST LABS | ANDA 208357 | AB | Jun 06, 2019 | |
| DESMOPRESSIN ACETATE | AM REGENT | ANDA 091374 | — | Feb 14, 2019 | |
| DESMOPRESSIN ACETATE×2 | ABHAI LLC | ANDA 210371 | AB | Jan 28, 2019 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | ZYDUS PHARMS | ANDA 091345 | AB | Oct 03, 2017 | |
| DESMOPRESSIN ACETATE | SAGENT PHARMS INC | ANDA 204695 | AP | Aug 22, 2017 | |
| DESMOPRESSIN ACETATE | SAGENT PHARMS INC | ANDA 204751 | AP | Aug 22, 2017 | |
| DESMOPRESSIN ACETATE×2 | HERITAGE PHARMA | ANDA 207880 | AB | May 26, 2017 | |
| DESMOPRESSIN ACETATE×2 | GLENMARK PHARMS LTD | ANDA 201831 | — | May 28, 2015 | |
| DESMOPRESSIN ACETATE×2 | NATCO PHARMA USA | ANDA 200653 | — | Jun 27, 2014 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | SUN PHARM | ANDA 078271 | — | Dec 23, 2013 | |
| DESMOPRESSIN ACETATE | SUN PHARM INDS LTD | ANDA 091280 | — | Jan 25, 2013 | |
| DESMOPRESSIN ACETATE | SUN PHARM INDS | ANDA 077212 | — | Apr 12, 2012 | |
| DESMOPRESSIN ACETATE×2 | APOTEX | ANDA 077414 | AB | Mar 07, 2006 | |
| DESMOPRESSIN ACETATE×2 | IMPAX LABS INC | ANDA 077122 | — | Jan 25, 2006 | |
| DESMOPRESSIN ACETATE×2 | ACTAVIS LABS FL INC | ANDA 076470 | — | Jul 01, 2005 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | APOTEX | ANDA 076703 | AB | Jan 27, 2005 | |
| DESMOPRESSIN ACETATE | HOSPIRA | ANDA 075220 | — | Aug 28, 2000 | |
| DESMOPRESSIN ACETATE | BEDFORD | ANDA 074575 | — | Feb 18, 2000 | |
| DESMOPRESSIN ACETATE PRESERVATIVE FREE | BEDFORD | ANDA 074574 | — | Feb 18, 2000 | |
| DESMOPRESSIN ACETATE | BAUSCH | ANDA 074830 | AB | Jan 25, 1999 | |
| DESMOPRESSIN ACETATE | MEITHEAL | ANDA 074888 | AP | Oct 15, 1997 |
Listed patents (9)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11963995 | May 21, 2029 | in 3 yr | U-2327 |
| 11020448 | May 21, 2029 | in 3 yr | U-2327 |
| 10137167 | May 21, 2029 | in 3 yr | U-2327 |
| 9974826 | Apr 13, 2030 | in 3 yr 10 mo | U-2326 |
| 11419914 | Jun 15, 2030 | in 4 yr 1 mo | U-3431 |
| 12090190 | Jun 15, 2030 | in 4 yr 1 mo | ProductU-4003 |
| 9539302 | Jun 15, 2030 | in 4 yr 1 mo | Product |
| 12343372 | Apr 03, 2044 | in 18 yr 1 mo | ProductU-4432 |
| 12214010 | Apr 03, 2044 | in 18 yr 1 mo | Product |
Desmopressin acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

